A number of factors have been identified that are related to sexual and injecting HIV transmission. We developed a probabilistic mathematical model to put these factors together and interpret risks in the context of individual behavior among injecting drug-using (IDU) couples in St. Petersburg, Russia. Some HIV-discordant couples have unprotected sex and sometimes inject drugs together but stay discordant for a long time, while some individuals acquire HIV on the first encounter. We considered existing estimates of HIV transmission risks through injecting and sexual contacts to develop a predictive survival model for an individual who is exposed to HIV through intimate relationships. We computed simulated survival curves for a number of behavioral scenarios and discussed sources of simulated uncertainty. We then applied the model to a longitudinal study of HIV-discordant couples and validated the model’s forecast. Although individual prediction of seroconversion time appeared impossible, the ability to rank behavioral patterns in terms of HIV risk and to estimate the probability of survival HIV-free will be important to educators and counselors.
References
[1]
Centers for Disease Control and Prevention (2012) Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. HIV Surveillance Supplemental Report, 2012; 17(No. 4). Avaliable: http://www.cdc.gov/hiv/topics/surveillan？ce/resources/reports/#supplemental.
[2]
HIV ESGoHTo (1992) Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 304(6830): 809–13.
[3]
Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW (2002) Reducing the risk of sexual HIV transmission, sexually transmitted diseases. 29(1): 38–43.
[4]
Royce RA, Sena A, Cates W, Cohen M (1997) Sexual Transmission of HIV N Engl J Med. 336: 1072–8.
[5]
Weller SC, Davis-Beaty K (2011) Condom effectiveness in reducing heterosexual HIV transmission (Review): Wiley and Sons; 2011.
[6]
Hudgens MG, Longini IM, Halloran ME, Choopanya K, Vanichseni S, et al. (2001) Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand. Journal of the Royal Statistical Society: Series C. 50(1): 1–14.
[7]
Kaplan EH, Heimer R (1992) A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 5: 1116–8.
[8]
Attia S, Egger M, Müller M, Zwahlen M, Low N (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy:systematic review and meta-analysis. AIDS. 23(11): 1397–404.
[9]
Baggaley RF, White RG, Hollingsworth TD, Boily MC (2013) Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples. Epidemiology 24(1): 110–21.
[10]
Castilla J, del Romero J, Hernando V, Marincovich B, Garcia S, et al. (2005) Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. JAIDS 40: 96–101.
[11]
Porco TC, Martin JN, Page-Shafer KA (2004) Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18: 81–8.
[12]
Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM (2008) Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 372: 314–20.
[13]
Zule WA (2013) Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. International Journal on Drug Policy 24(1): 1–7.
[14]
Leynaert B, Downs AM, de Vincenzi I (1998) European Study Group on Heterosexual Transmission of HIV. Heterosexual transmission of HIV: variability of infectivity throughout the course of infection. Am J Epidemiol 148(1): 88–96.
[15]
Chin J (1992) Present and future dimensions of the HIV/AIDS pandemic. In: Rossi GB, Beth-Giraldo E, Chieco-Bianchi L, Dianzi F, Giraldo G, Verani P, editors. Science Challenging AIDS. Basel: Karger. p. 33–50.
